Medine.co.uk

4:1 Iodine Concentrate 2.5% W/V, Teat Dip Or Spray Solution

Revised: January 2013

AN: 00116/2012

SUMMARY OF PRODUCT CHARACTERISTICS


1. NAME OF THE VETERINARY MEDICINAL PRODUCT

4:1 Iodine Concentrate 2.5% w/v, Teat Dip or Spray Solution


2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Active Substance: 2.5% w/v available Iodine

Other Constituents:

25.0% w/v Glycerol

0.1% w/v Ethoxylated Lanolin

For full list of excipients see section 6.1


PHARMACEUTICAL FORM


Concentrate for Teat Dip / Teat Spray Solution

Description: Mobile brown liquid


4. CLINICAL PARTICULARS


4.1 Target species

Lactating dairy cattle.


4.2 Indications for use, specifying the target species


As an aid in the prevention of mastitis in lactating dairy cattle. After each milking the diluted product is applied directly to the teats by spraying or by teat dipping with a teat cup.


4.3 Contra-indications

None


4.4 Special warnings for each target species

For external use only. Teat dip cups should be emptied after each milking and washed thoroughly before re-use. Wash and dry udders and teats before next milking.


4.5 Special precautions for use

Special precautions for use in animals

None


Special precautions to be taken by the person administering the medicinal product to animals


CONCENTRATE

The following safety phrases refer to the concentrated product only and do not apply once the product is diluted to the working solution: Risk of serious damage to eyes. Wear eye/face protection when preparing the dip or spray.


DILUTED WORKING SOLUTION

When using as a spray, avoid working in spray mist.

Avoid contact with eyes.

In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.

If swallowed, seek medical advice immediately and show this container or label.

Hands and exposed skin should be washed after using this product.

Keep away from food, drink and animal feedstuffs.

Do not eat, drink or smoke whilst using the product


4.6 Adverse reactions (frequency and seriousness)

None noted.


4.7 Use during pregnancy, and lactation or lay


The product is a medicinal disinfectant intended as an aid against mastitis. It is designed to be used on lactating dairy cattle and is applied externally without risk to the cow.


4.8 Interaction with other medicinal products aments and other forms of interaction

Do not mix with other products.


4.9 Amounts to be administered and administration route


The product is a concentrated teat dip which is diluted and then applied directly to the teats of dairy cattle by either semi-automatic hand held spray equipment or by dipping using a teat cup containing the product.


Post-milking teat dipping / spraying: This concentrate requires to be diluted just prior to use. Prepare a solution of 1 part product to 4 parts clean water. Prepare a fresh solution daily. Fill the teat cup two thirds full with this solution. After each cow has been milked, dip each teat ensuring that the entire surface of the teat comes into contact with the solution. Refill the teat cup as necessary from the solution. Teat cups should be emptied after use and washed before re-use. Wash and dry teats and udders before next milking.


Spraying: Prepare a solution of 1 part product to 4 parts clean water. Prepare a fresh solution daily. After each cow has been milked, spray the entire surface of each teat with the solution. Wash and dry teats and udders before next milking.


Udder washing: When the teats are dirty clean them with a paper towel soaked in 12 ml of product in 8 litres of clean water. When mastitis is in the herd use 12 ml of product in 4 litres of clean water. Prepare a fresh solution daily. Use one disposable paper towel for each cow


Cluster dipping: Between transferring clusters from one cow to the next, plunge the clusters 3 times into a solution prepared by adding 12 ml of teat dip concentrate to 8 litres of water.


4.10 Overdose (symptoms, emergency procedures, antidotes) if necessary


The limited external use of this product makes an overdose very unlikely.


4.11 Withdrawal period(s)

Meat – zero days / Milk – zero hours


5. PHARMACOLOGICAL PROPERTIES


Pharmacotherapeutic group: Products for teats and udder, disinfectants


ATCVet code:QG52A


5.1 Pharmacodynamic properties


Iodine is a halogen element being a member of Group VII of the Periodic Table. In common with other members of this group, notably chlorine, it is a broad-spectrum bactericide useful for skin disinfection.


6. PHARMACEUTICAL PARTICULARS


6.1 List of excipients


Glycerol

Ethoxylated Lanolin

Hydroiodic Acid

Alcohol 8 mole ethoxylate

Potable Water


6.2 Incompatibilities


Incompatible with Chlorhexidine-based teat dips.


6.3 Shelf life


Shelf life of the veterinary medicinal product as packaged for sale; 1 year.


6.4 Special precautions for storage


For one milking only when transferred to teat dip cup.

Dilute immediately before use, any unused diluted product should be discarded.

Do not store above 25C.

Protect from frost.

If the contents freeze, it is important that they are thoroughly thawed and mixed before use.

Protect from direct sunlight.


6.5 Nature and composition of immediate packaging


Available in 5 litre blue opaque high density polyethylene Jerri can closed with a white opaque high density polyethylene screw fit cap.


Special precautions for the disposal of unused veterinary medicinal products or waste materials derived from the use of such products, if appropriate.


Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements. To dispose of unused product to land you must have an authorisation under the Groundwater Regulations 2009. Harmful to fish and other aquatic life. Do not contaminate ponds, waterways or ditches with the product or empty container.


7. MARKETING AUTHORISATION HOLDER


Kilco (International) Ltd.

Broomhouses 2 Industrial Estate

Old Glasgow Road

Lockerbie

Dumfriesshire

DG11 2SD



8. MARKETING AUTHORISATION NUMBER(S)


Vm 21357/4018


9. DATE OF FIRST AUTHORISATION


Date: 15 January 1986


10. DATE OF REVISION OF THE TEXT

Date: January 2013


Approved:

18/01/13

Page 5 of 5